CT2 Talk | Immune Checkpoint Blockade Induces Distinct Alterations in the Microenvironment of Primary and Metastatic Brain Tumors

Monday, November 6, 3:00pm - 4:00pm (EST)

Time shown in-04:00 America, New York

Robert M. Prins, PhD
Professor of Neurosurgery and Molecular and Medical Pharmacology
Member, Brain Research Institute, Jonsson Comprehensive Cancer Center, and Parker Institute for Cancer Immunotherapy

Dr. Robert Prins is a tumor immunologist and Professor with dual appointments in the departments of Neurosurgery and Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. Dr. Prins currently directs the Brain Tumor Immunotherapy Research Lab and oversees the training of multiple graduate students, medical students, residents, and hematology/oncology fellows.

Please fill out the information below to register for the event.

Going
Interested
Can't go

Name

Attending

You're going to "CT2 Talk | Immune Checkpoint Blockade Induces Distinct Alterations in the Microenvironment of Primary and Metastatic Brain Tumors".

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Add to Calendar 2023/11/06 12:00:00 2023/11/06 13:00:00 America/Los_Angeles CT2 Talk | Immune Checkpoint Blockade Induces Distinct Alterations in the Microenvironment of Primary and Metastatic Brain Tumors Robert M. Prins, PhD
Professor of Neurosurgery and Molecular and Medical Pharmacology
Member, Brain Research Institute, Jonsson Comprehensive Cancer Center, and Parker Institute for Cancer Immunotherapy

Dr. Robert Prins is a tumor immunologist and Professor with dual appointments in the departments of Neurosurgery and Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. Dr. Prins currently directs the Brain Tumor Immunotherapy Research Lab and oversees the training of multiple graduate students, medical students, residents, and hematology/oncology fellows. false MM/DD/YYYY 60 OPAQUE aRHTJAtebzuytgVCsmlE218689

You're interested in "CT2 Talk | Immune Checkpoint Blockade Induces Distinct Alterations in the Microenvironment of Primary and Metastatic Brain Tumors".

We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.

Thank you!

Your changes have been saved. Thanks for keeping us updated.

Robert M. Prins, Ph.D.

Link: